Dr. John Cush RheumNow
3 years 5 months ago
Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances
This webinar will feature highlights from these lectures followed by live audience Q & A:
-New Therapies for PMR & GCA
-Assessment of GCA and PMR
-GPA Treatment Choices
https://t.co/MQBAEmUvuC https://t.co/qh2By6a3Kf
Dr. John Cush RheumNow
3 years 5 months ago
JAMA: n 2020, 42 114 deaths in the US were related to falls, with 86% occurring among adults aged >65 years. Falls are a leading cause of injury and leading causes of death among older adults in the US - And these #s are increasing betw '99 & 2020 https://t.co/3sXSCXZ8Q6 https://t.co/PSi3xcT8fJ
Researchers from Harvard have reported their analysis showing that the large increase in colchicine cost in 2010 was associated with an immediate decrease in colchicine prescription use, with a 10 year increase in emergency department and rheumatology gout visits suggesting poorer gout control.
Dr. John Cush RheumNow
3 years 5 months ago
In 2020 Filgotinib (Jyseleca) did not seek FDA approval over FDA concerns & pending RCTs on safety & spermatogenesis. Now the results (MANTA & MANTA-RAy) are published showing FIL has no effect on semen & sex hormones. But still no filgotinib in USA https://t.co/4IHoOpylXm https://t.co/VPqW5Ktcc4
Dr. John Cush RheumNow
3 years 5 months ago
ICYMI: Psoriatic Arthritis and Pregnancy
Christina Chambers, PhD, MPH delivered a standout lecture on psoriatic arthritis and pregnancy on Saturday, the first day of RheumNow Live 2023.
Check out the summary from Dr Eric Dein ( @ericdeinmd )
https://t.co/Lo8FpewC4V https://t.co/ntp47kwKbK
Dr. John Cush RheumNow
3 years 5 months ago
One in Ten has Autoimmune Disease
A UK population-based study suggests that autoimmune diseases affect approximately one in ten individuals.
https://t.co/WpsnDGiNHt https://t.co/llGcOFQMmx
Dr. John Cush RheumNow
3 years 5 months ago
Watch: Insights into the Future of Osteoarthritis
RheumNow Live 2023: Philip Conaghan, MBBS, PhD, University of Leeds, Biomedical Research Centre
https://t.co/xjccnULOBn https://t.co/inIDFDN7GA
Genetic blood tests indicated that Bruton's tyrosine kinase (BTK) and a cytokine called APRIL were overexpressed in patients with primary Sjögren's syndrome who subsequently developed lymphoma, French researchers reported, suggesting that BTK inhibitors might be useful in this population.
Dr. John Cush RheumNow
3 years 5 months ago
RNL23 Replays (5.6.2023)
This week on the podcast we feature replay content from RNL 2023, cannabis effects on pain and sleep, and what drives PJP risk the most - steroids or RTX?
https://t.co/hmJQBq3krb https://t.co/xeh0gOqoTf
Dr. John Cush RheumNow
3 years 5 months ago
Downs Syndrome (1/700) & autoimmune mechanisms - Downs has a 4-6 fold higher risk of JIA, type 1 diabetes, autoimmune thyroid disease and coeliac disease. https://t.co/wVUDRCS96I https://t.co/RosPAkRnPA
Dr. John Cush RheumNow
3 years 5 months ago
Thanks to these Rheumatology Influencers who were tweeting & teaching from RheumNow Live 2023!
Look for all the RNL23 Replays this month- videos, podcasts, articles, & tweets
@ericdeinmd @doctorRBC @NoufAhmedAlham2 @Janetbirdope @uptoTate @anisha_dua @DrLauraCoates https://t.co/AgvQ06dp3Z
Dr. John Cush RheumNow
3 years 5 months ago
in 2022 COVID slid from the #3 to the #4 cause of death in USA, accounting for nearly a quarter million deaths, a 47 percent decrease from the 462,193 Covid-related deaths in 2021. Most COVID deaths occured in the first few mos of 2022 https://t.co/qervCp0P87 https://t.co/WN7DvsFhNC
